As of 11:50am ET
| +0.0131 / +0.32%|
The 7 analysts offering 12-month price forecasts for Verona Pharma PLC have a median target of 26.29, with a high estimate of 58.00 and a low estimate of 8.00. The median estimate represents a +545.82% increase from the last price of 4.07.
The current consensus among 7 polled investment analysts is to Buy stock in Verona Pharma PLC. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.